New weight loss drugs spark eating disorder concerns in teens

Most teens treated for obesity report symptoms of depression and eating disorders, study says

BOSTON - There is concern over the newest weight loss drugs sparking eating disorders in teens.

Newer GLP-1 weight loss drugs, like Wegovy, have been approved for kids 12 and up and the number of teenagers taking these medications rose nearly sevenfold between 2020 and 2023. But a recent study found that nearly 80% of teens seeking treatment for obesity reported symptoms of depression and eating disorders.

According to WebMD, mental health experts are worried about striking a balance between helping a teen lose weight with these new drugs, which suppress appetite and alter metabolism, without triggering an eating disorder, like binge-eating or bulimia, or making one worse. Experts said part of obesity treatment should be to screen and monitor for disordered eating, which doesn't always happen.

Read more
f

We and our partners use cookies to understand how you use our site, improve your experience and serve you personalized content and advertising. Read about how we use cookies in our cookie policy and how you can control them by clicking Manage Settings. By continuing to use this site, you accept these cookies.